Everus (NYSE:ECG) Stock Price Expected to Rise, Oppenheimer Analyst Says

Everus (NYSE:ECGFree Report) had its price target boosted by Oppenheimer from $70.00 to $80.00 in a research report sent to investors on Tuesday,Benzinga reports. The brokerage currently has an outperform rating on the stock.

Several other equities research analysts also recently weighed in on ECG. DA Davidson assumed coverage on shares of Everus in a research note on Monday, November 4th. They set a “neutral” rating and a $55.00 target price on the stock. Wolfe Research began coverage on Everus in a research report on Tuesday, December 3rd. They set a “peer perform” rating on the stock. Finally, Stifel Nicolaus boosted their price target on shares of Everus from $71.00 to $78.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th.

Check Out Our Latest Stock Report on ECG

Everus Stock Performance

NYSE:ECG opened at $66.82 on Tuesday. The stock’s fifty day moving average price is $64.99. Everus has a 52 week low of $40.05 and a 52 week high of $73.73. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.50 and a current ratio of 1.58.

About Everus

(Get Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Recommended Stories

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.